comparemela.com

Latest Breaking News On - Real world evidence studies - Page 1 : comparemela.com

Global Angina Pectoris Drugs Market Report 2024: Escalating

Albert Labs listing will allow us to deliver promise of psychedelic therapy to patients in need

Albert Labs Chief Commercial Officer Graeme Mcfarlane joins Proactive London s Katie Pilbeam to talk about their upcoming listing which he.

Adding to their Expert Team, Albert Labs Announces the Formation and Chairs of its Two Advisory Boards

Share: Professor Jo Neill and Parminder Singh bring psychopharmacology and IP protection & licensing expertise to a company pursuing psilocybin-based therapies VANCOUVER, BC, May 25, 2021 /CNW/ - Albert Labs, an innovative developer of psychedelics-based therapeutics addressing urgent and unmet mental health indications through Real World Evidence (RWE) studies in the UK and across Europe, is pleased to announce the chairs of its Clinical and Scientific Advisory Boards. The company welcomes Professor Jo Neill as the Chair of Albert Labs Clinical Advisory Board and Parminder Singh Chair of its Scientific Advisory Board. We are delighted to have such authority with Jo and Parminder, they bring a wealth of knowledge and expertise in each of their disciplines and we look forward to working with them in driving our Clinical and Scientific Advisory boards said Graeme McFarlane, Chief Commercial Officer of Albert Labs.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.